Allogene Therapeutics Inc (ALLO)
2.21
+0.10
(+4.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.26
+0.05
(+2.26%)
After-Hours: 20:00
Allogene Therapeutics Price: 2.21 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 2.12 | 2.23 | 2.09 | 2.21 | 1.417M |
Nov 21, 2024 | 2.06 | 2.14 | 2.005 | 2.11 | 1.896M |
Nov 20, 2024 | 2.11 | 2.14 | 1.99 | 2.05 | 2.448M |
Nov 19, 2024 | 2.13 | 2.14 | 2.04 | 2.12 | 2.814M |
Nov 18, 2024 | 2.30 | 2.32 | 2.14 | 2.15 | 2.924M |
Nov 15, 2024 | 2.52 | 2.52 | 2.26 | 2.27 | 3.091M |
Nov 14, 2024 | 2.72 | 2.753 | 2.46 | 2.46 | 2.623M |
Nov 13, 2024 | 2.86 | 2.945 | 2.71 | 2.72 | 1.811M |
Nov 12, 2024 | 3.01 | 3.05 | 2.825 | 2.84 | 2.275M |
Nov 11, 2024 | 3.05 | 3.169 | 2.985 | 3.09 | 2.903M |
Nov 08, 2024 | 3.24 | 3.26 | 2.95 | 3.08 | 2.839M |
Nov 07, 2024 | 3.26 | 3.360 | 3.165 | 3.19 | 2.516M |
Nov 06, 2024 | 3.05 | 3.29 | 2.99 | 3.22 | 4.037M |
Nov 05, 2024 | 2.96 | 3.04 | 2.88 | 2.99 | 2.599M |
Nov 04, 2024 | 2.73 | 3.025 | 2.655 | 3.00 | 3.165M |
Nov 01, 2024 | 2.57 | 2.83 | 2.57 | 2.72 | 2.535M |
Oct 31, 2024 | 2.64 | 2.73 | 2.54 | 2.555 | 2.208M |
Oct 30, 2024 | 2.74 | 3.01 | 2.64 | 2.64 | 2.056M |
Oct 29, 2024 | 2.68 | 3.01 | 2.665 | 2.80 | 3.285M |
Oct 28, 2024 | 2.48 | 2.75 | 2.45 | 2.68 | 3.090M |
Oct 25, 2024 | 2.56 | 2.58 | 2.44 | 2.44 | 2.090M |
Oct 24, 2024 | 2.77 | 2.78 | 2.535 | 2.54 | 2.053M |
Oct 23, 2024 | 2.80 | 2.845 | 2.70 | 2.77 | 3.305M |
Oct 22, 2024 | 2.76 | 2.83 | 2.68 | 2.80 | 1.117M |
Oct 21, 2024 | 2.82 | 2.90 | 2.78 | 2.80 | 1.568M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.05
Minimum
Nov 20 2024
54.04
Maximum
May 22 2020
15.90
Average
10.82
Median
Price Benchmarks
ANI Pharmaceuticals Inc | 56.91 |
AIM ImmunoTech Inc | 0.2101 |
Perspective Therapeutics Inc | 3.47 |
Protalix BioTherapeutics Inc | 1.69 |
Armata Pharmaceuticals Inc | 2.25 |
Price Related Metrics
PS Ratio | 4679.16 |
Price to Book Value | 0.9992 |
Earnings Yield | -70.59% |
Market Cap | 463.38M |